SLS Stock-Based Compensation
Sellas Life Sciences Group Inc · Stock-Based Compensation
SLS Stock-Based Compensation
Latest reported$2.76Mperiod ending
SLS Stock-Based Comp ($0.00 → $2.76M)
Annual stock-based compensation
High-resolution chart · PNG
SLS stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 1,956,000 | |
| 1,564,000 | |
| 1,390,000 | |
| 1,726,000 | |
| 1,011,000 | |
| 578,000 | |
| 573,000 | |
| 395,000 | |
| 3,169,000 | |
| 2,264,000 | |
| 1,931,000 | |
| 5,387,000 | |
| 2,530,000 | |
| 1,394,000 | |
| 3,001,000 | |
| 4,368,000 | |
| 4,202,000 | |
| 3,824,000 | |
| 0 | |
| 0 |